Product NDC: | 61715-011 |
Proprietary Name: | Sinus Congestion and Pain Severe |
Non Proprietary Name: | ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE |
Active Ingredient(s): | 325; 200; 5 mg/1; mg/1; mg/1 & nbsp; ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61715-011 |
Labeler Name: | Kinray Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20130509 |
Package NDC: | 61715-011-24 |
Package Description: | 2 BLISTER PACK in 1 CARTON (61715-011-24) > 12 TABLET, COATED in 1 BLISTER PACK |
NDC Code | 61715-011-24 |
Proprietary Name | Sinus Congestion and Pain Severe |
Package Description | 2 BLISTER PACK in 1 CARTON (61715-011-24) > 12 TABLET, COATED in 1 BLISTER PACK |
Product NDC | 61715-011 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20130509 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Kinray Inc. |
Substance Name | ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 325; 200; 5 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |